Clinical Trial Update: Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing low-dose versus standard-dose indomethacin for prevention of post-ERCP pancreatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Pancreatitis

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Changhai Hospital | Conditions: Post-ERCP Pancreatitis | Phase 4 | Status: RECRUITING